Sana Biotechnology, Inc. Common Stock

SANANASDAQUSD
3.14 USD
0.02 (0.60%)🟢PRE MARKET (AS OF 07:02 AM EDT)
🟢Market: OPEN

Shares of Sana Biotechnology, Inc. Common Stock (SANA) are trading at $3.14. Both sides of the analysis point lower: technicals flash "Strong Sell" and fundamentals confirm with a "Sell" reading. This is driven by a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. On valuation, SANA trades roughly in line with sector averages — neither particularly cheap nor expensive.

Technical & fundamental data as of Sep 15, 2026.

Open?$3.20
High?$3.25
Low?$3.14
Prev. Close?$3.16
Volume?3.3K
Avg. Volume?2.8M
VWAP?$3.18
Rel. Volume?0.00x
Bid / Ask
Bid?$3.12 × 100
Ask?$3.64 × 100
Spread?$0.52
Midpoint?$3.38
Valuation & Ratios
Market Cap?946.0M
Shares Out?299.4M
Float?165.9M
Float %?59.6%
P/E Ratio?N/A
P/B Ratio?6.12
EPS?-$0.71
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Sana Biotechnology Inc is a biotechnology company. The company develops engineered cells as medicines and therapies to treat diseases. It is engaged in developing cell engineering programs across a broad array of therapeutic areas with unmet treatment needs, including oncology, diabetes, B-cell-mediated autoimmune, and central nervous system (CNS) disorders, among others. Its pipeline of product candidates comprises SC291, SC262, UP421, and others.
Employees
142
Market Cap
958.0M
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Listed
2021-02-04
Address
188 EAST BLAINE STREET, SUITE 350
SEATTLE, WA
Phone: (206) 701-7914
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)? Bearish(-3/3)
Medium-Term (Wave)? Bearish(-3/3)
Short-Term (Ripple)? Bearish(-1/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
0
Momentum?
50
Short Sent.?
30
Piotroski F-Score?0/9Weak
Altman Z-Score?-5.85Distress
Confidence?59%Low
Full Fundamental Analysis →
Short InterestSqueeze Risk
Short % of Float?25.06%Squeeze Risk
Short Interest?41.6M
Days to Cover?16.1
Free Float165.9M
Avg Daily Volume2.6M
Settlement Date2026-08-31
Financial Health
Current Ratio?1.38Adequate
Quick Ratio?1.38Adequate
Cash Ratio?0.46Low
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
83/100
P/E?
N/A
P/B?
Peers
100
S&P
30
6.12FAIR
P/S?
N/A
P/FCF?
N/A
EV/EBITDA?
S&P
97
-4.3CHEAP
EV/Sales?
N/A
Returns & Efficiency
ROE?
S&P
3
-137.0%WEAK
ROA?
S&P
3
-49.1%WEAK
Cash Flow & Enterprise
FCF?$-135062000
Enterprise Value?$888.9M
Fundamentals ratios updated end of day